Advanced search
Publication Cover
Future Oncology Volume 5, 2009 - Issue 8
Submit an article Journal homepage
159
Views
1
CrossRef citations to date
0
Altmetric
Review

Epithelial–Mesenchymal Transition in Mouse Mammary Tumorigenesis

Enrico Radaellia Department of Veterinary Pathology, Hygiene and Public Health, Section of Veterinary and Avian Pathology, Faculty of Veterinary Medicine, University of Milan, Via Celoria, 10 20133Milano, ItalyView further author information
,
Patrizia Damonteb Dipartimento di Medicina Sperimentale (DIMES), Università di Genova, Largo Rosanna Benzi 1o, 16132Genova, ItalyView further author information
&
Robert D Cardiffc Center for Comparative Medicine University of California, Davis, County Road 98 and Hutchison Drive, Davis, CA95616, USA. [email protected]Correspondence[email protected]
View further author information
Pages 1113-1127 | Published online: 26 Oct 2009

Bibliography

  • Berx G , RaspeE, ChristoforiG, ThieryJP, SleemanJP: Pre-emting metastasis? Recapitulation of morphogenetic processes in cancer.Clin. Exp. Metastasis24(8), 587–597 (2007).
  • Moustakas A , HeldinCH: Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression.Cancer Sci.98(10), 1512–1520 (2007).
  • Thiery JP : Epithelial-mesenchymal transitions in development and pathologies.Curr. Opin. Cell Biol.15(6), 740–746 (2003).
  • Hugo H , AcklandML, BlickTet al.: Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression.J. Cell Physiol.213(2), 374–383 (2007).
  • Wells A , YatesC, ShepardCR: E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas.Clin. Exp. Metastasis25(6), 621–628 (2008).
  • Karreth F , TuvesonDA: Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis.Cancer Biol. Ther.3(11), 1058–1059 (2004).
  • Apolant H : Die epithelialen geschwülste der maus.Arbeiten a.d. Koniglchn Inst. F. Expt.Ther. zu Frankfurt a.M.1, 7–68 (1906).
  • Cardiff RD , KenneyN: Mouse mammary tumor biology: a short history.Adv. Cancer Res.98, 53–116 (2007).
  • Crisp E : Malignant tumor on the pectoral muscle of a mouse (m. Musculus).Transactions of the Pathological Society of London5, 348 (1854).
  • Morau H : Recherches esperimentalis sur la transmissibilite de certain acoplasmes (epithliomas cylindirques).Arch. de Med. Expl. et d’ anat. Path.6, 677 (1894).
  • Haaland M : Spontaneous tumors in mice.Imperial Cancer Research Fund Scientific Report4, 1–114 (1911).
  • Ehrlich P , ApolantH: Ueber spontane mischtumoren der maus.Berliner Klinische Wochenschrift (44), 1–3 (1907).
  • Woglom WH : The study of experimental cancer research. A review. In: George Crocker Special Research Fund. Studies in Cancer and Allied Subjects. Columbia University Press, NY, USA, 1 (1913).
  • Borrel A : Epithelioses infecticuses of epitheliomas.Ann. de L’Inst. Pasteur17, 81–118 (1903).
  • Borrel A : Parasitisme et tumours.Ann. de L’Inst. Pasteur24, 778 (1910).
  • Murray JA : Cancerous ancestry and the incidence of cancer in mice.Imperial Cancer Research Fund Scientific Report4, 114–130 (1911).
  • Jensen CO : Experimentelle untersuchungen uber krebs bei mausen.Centbl. F. Bakt.34, 28 and 122 (1903).
  • Williams WR : What is Jensen’s tumor?Lancet,1285–1286 (1906).
  • Bashford EF : Introduction.Investigations of the Imperial Cancer Research Fund Scientific Report.,4, vii–xxi (1911).
  • Ewing J : Neoplastic Diseases: A Text-Book on Tumors.WB Saunders Company, PA, USA (1919).
  • Little CC , TyzzerEE: Further experimental studies on the inheritance of susceptibility to a transplantable carcinoma (JA) of the Japanese waltzing mouse.J. Med. Res.33, 393–427 (1916).
  • Dunn TB : Morphology of mammary tumors in mice with and without the agent.Acta Unio. Int. Contra. Cancrum7(2), 234–237 (1951).
  • Dunn TB : Morphology and histogenesis of mammary tumors. In: Symposium on mammary tumors in mice. Moulton FR (Ed.). The American Association for the Advancement of Science, Washington, DC, USA 13–38 (1945).
  • Young LJ , CardiffRD, AshleyRL: Long-term primary culture of mouse mammary tumor cells: Production of virus.J. Natl Cancer Inst.54(5), 1215–1221 (1975).
  • Yagi MJ : Characteristics of mammary tumor cultures from four mouse strains infected with mammary tumor virus.Cancer Res.35(2), 370–373 (1975).
  • Parks WP , ScolnickEM: Murine mammary tumor cell clones with varying degrees of virus expression.Virology55(1), 163–173 (1973).
  • Strange R , Aguilar-CordovaE, YoungLJ, BillyHT, DandekarS, CardiffRD: Harvey-ras mediated neoplastic development in the mouse mammary gland.Oncogene4(3), 309–315 (1989).
  • Cardiff RD : Genomic pathology for genomic biology.Pathologica100(1), 3–5 (2008).
  • Cardiff RD , SinnE, MullerW, LederP: Transgenic oncogene mice. Tumor phenotype predicts genotype.Am. J. Pathol.139(3), 495–501 (1991).
  • Rosner A , MiyoshiK, Landesman-BollagEet al.: Pathway pathology: Histological differences between erbb/ras and wnt pathway transgenic mammary tumors.Am. J. Pathol.161(3), 1087–1097 (2002).
  • Cardiff RD , MunnRJ, GalvezJJ: The tumor pathology of genetically engineered mice: a new approach to molecular pathology. In: The mouse in biomedical research: Experimental biology and oncology. Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith Al (Eds). Elsevier, Inc, NY, USA 581–622 (2006).
  • Cui XS , DonehowerLA: Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.Oncogene19(52), 5988–5996 (2000).
  • White DE , CardiffRD, DedharS, MullerWJ: Mammary epithelial-specific expression of the integrin-linked kinase (ilk) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.Oncogene20(48), 7064–7072 (2001).
  • Thiery JP , TuckerGC, BoyerBet al.: [Mechanisms of induced epithelium-fibroblast conversion in a line of vesical cancer in the rat].Pathol. Biol. (Paris)37(9), 1034 (1989).
  • Boyer B , TuckerGC, VallesAM, GavrilovicJ, ThieryJP: Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line.Int. J. Cancer Suppl.4, 69–75 (1989).
  • Moody SE , PerezD, PanTCet al.: The transcriptional repressor snail promotes mammary tumor recurrence.Cancer Cell8(3), 197–209 (2005).
  • Gunther EJ , MoodySE, BelkaGKet al.: Impact of p53 loss on reversal and recurrence of conditional wnt-induced tumorigenesis.Genes Dev.17(4), 488–501 (2003).
  • Ahmed F , WyckoffJ, LinEYet al.: Gfp expression in the mammary gland for imaging of mammary tumor cells in transgenic mice.Cancer Res.62(24), 7166–7169 (2002).
  • Condeelis J , PollardJW: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.Cell124(2), 263–266 (2006).
  • Ingman WV , WyckoffJ, Gouon-EvansV, CondeelisJ, PollardJW: Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland.Dev. Dyn.235(12), 3222–3229 (2006).
  • Wyckoff J , WangW, LinEYet al.: A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors.Cancer Res.64(19), 7022–7029 (2004).
  • Wyckoff JB , WangY, LinEYet al.: Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.Cancer Res.67(6), 2649–2656 (2007).
  • Kedrin D , Van RheenenJ, HernandezL, CondeelisJ, SegallJE: Cell motility and cytoskeletal regulation in invasion and metastasis.J. Mammary Gland Biol. Neoplasia12(2–3), 143–152 (2007).
  • Pecina-Slaus N : Tumor suppressor gene E-cadherin and its role in normal and malignant cells.Cancer Cell Int.3(1), 17 (2003).
  • Becker KF , AtkinsonMJ, ReichUet al.: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.Cancer Res.54(14), 3845–3852 (1994).
  • Berx G , Cleton-JansenAM, NolletFet al.: E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers.EMBO J.14(24), 6107–6115 (1995).
  • Goto T , NakanoM, ItoS, EharaH, YamamotoN, DeguchiT: Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.Urology70(1), 127–130 (2007).
  • Lin J , DinneyCP, GrossmanHBet al.: E-cadherin promoter polymorphism (c-160a) and risk of recurrence in patients with superficial bladder cancer.Clin. Genet.70(3), 240–245 (2006).
  • Cattaneo F , VenesioT, MolatoreSet al.: Functional analysis and case–control study of -160c/a polymorphism in the E-cadherin gene promoter: Association with cancer risk.Anticancer Res.26(6B), 4627–4632 (2006).
  • Caldeira JR , PrandoEC, QuevedoFC, NetoFA, RainhoCA, RogattoSR: Cdh1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.BMC Cancer6, 48 (2006).
  • Prasad CP , MirzaS, SharmaGet al.: Epigenetic alterations of cdh1 and apc genes: Relationship with activation of wnt/β-catenin pathway in invasive ductal carcinoma of breast.Life Sci.83(9–10), 318–325 (2008).
  • Rodenhiser DI , AndrewsJ, KennetteWet al.: Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.Breast Cancer Res.10(4), R62 (2008).
  • Dhillon VS , YoungAR, HusainSA, AslamM: Promoter hypermethylation of mgmt, cdh1, rar-β and syk tumor suppressor genes in granulosa cell tumours (gcts) of ovarian origin.Br. J. Cancer90(4), 874–881 (2004).
  • Horikawa Y , SuganoK, ShigyoMet al.: Hypermethylation of an E-cadherin (cdh1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.J. Urol.169(4), 1541–1545 (2003).
  • Lee EJ , LeeBB, HanJet al.: Cpg island hypermethylation of E-cadherin (cdh1) and integrin α4 is associated with recurrence of early stage esophageal squamous cell carcinoma.Int. J. Cancer123(9), 2073–2079 (2008).
  • Poplawski T , TomaszewskaK, GalickiM, MorawiecZ, BlasiakJ: Promoter methylation of cancer-related genes in gastric carcinoma.Exp. Oncol.30(2), 112–116 (2008).
  • Peinado H , OlmedaD, CanoA: Snail, Zeb and bhlh factors in tumor progression: An alliance against the epithelial phenotype?Nat. Rev. Cancer7(6), 415–428 (2007).
  • Chua HL , Bhat-NakshatriP, ClareSE, MorimiyaA, BadveS, NakshatriH: Nf-κb represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of zeb-1 and zeb-2.Oncogene26(5), 711–724 (2007).
  • Huang D , DuX: Crosstalk between tumor cells and microenvironment via wnt pathway in colorectal cancer dissemination.World J. Gastroenterol.14(12), 1823–1827 (2008).
  • Spoelstra NS , ManningNG, HigashiYet al.: The transcription factor zeb1 is aberrantly expressed in aggressive uterine cancers.Cancer Res.66(7), 3893–3902 (2006).
  • Yang J , ManiSA, DonaherJLet al.: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.Cell117(7), 927–939 (2004).
  • Come C , MagninoF, BibeauFet al.: Snail and slug play distinct roles during breast carcinoma progression.Clin. Cancer Res.12(18), 5395–5402 (2006).
  • Leong KG , NiessenK, KulicIet al.: Jagged1-mediated notch activation induces epithelial-to-mesenchymal transition through slug-induced repression of E-cadherin.J. Exp. Med.204(12), 2935–2948 (2007).
  • Wanami LS , ChenHY, PeiroS, Garcia De HerrerosA, BachelderRE: Vascular endothelial growth factor-α stimulates snail expression in breast tumor cells: Implications for tumor progression.Exp. Cell Res.314(13), 2448–2453 (2008).
  • Mani SA , YangJ, BrooksMet al.: Mesenchyme forkhead 1 (foxc2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.Proc. Natl Acad. Sci. USA104(24), 10069–10074 (2007).
  • Lo HW , HsuSC, XiaWet al.: Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial–mesenchymal transition in cancer cells via up-regulation of twist gene expression.Cancer Res.67(19), 9066–9076 (2007).
  • Elliott BE , HungWL, BoagAH, TuckAB: The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer.Can. J. Physiol. Pharmacol.80(2), 91–102 (2002).
  • Xian W , SchwertfegerKL, Vargo-GogolaT, RosenJM: Pleiotropic effects of fgfr1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model.J. Cell Biol.171(4), 663–673 (2005).
  • Watson MA , YlaganLR, TrinkausKMet al.: Isolation and molecular profiling of bone marrow micrometastases identifies twist1 as a marker of early tumor relapse in breast cancer patients.Clin. Cancer Res.13(17), 5001–5009 (2007).
  • Loric S , ParadisV, GalaJLet al.: Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer.Eur. J. Cancer37(12), 1475–1481 (2001).
  • Mason MD , DaviesG, JiangWG: Cell adhesion molecules and adhesion abnormalities in prostate cancer.Crit. Rev. Oncol. Hematol.41(1), 11–28 (2002).
  • Ray ME , MehraR, SandlerHM, DaignaultS, ShahRB: E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes.J. Urol.176(4 Pt 1), 1409–1414; discussion 1414 (2006).
  • Graham TR , ZhauHE, Odero-MarahVAet al.: Insulin-like growth factor-I-dependent up-regulation of zeb1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.Cancer Res.68(7), 2479–2488 (2008).
  • Udayakumar TS , NagleRB, BowdenGT: Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.Prostate58(1), 66–75 (2004).
  • Cao J , ChiarelliC, RichmanO, ZarrabiK, KozarekarP, ZuckerS: Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer.J. Biol. Chem.283(10), 6232–6240 (2008).
  • Yuen HF , ChuaCW, ChanYP, WongYC, WangX, ChanKW: Significance of twist and E-cadherin expression in the metastatic progression of prostatic cancer.Histopathology50(5), 648–658 (2007).
  • Vogelmann R , Nguyen-TatMD, GiehlK, AdlerG, WedlichD, MenkeA: TGF-β-induced downregulation of E-cadherin-based cell–cell adhesion depends on pi3-kinase and pten.J. Cell Sci.118(Pt 20), 4901–4912 (2005).
  • Gotzmann J , FischerAN, ZojerMet al.: A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes.Oncogene25(22), 3170–3185 (2006).
  • Lee TK , PoonRT, YuenAPet al.: Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.Clin. Cancer Res.12(18), 5369–5376 (2006).
  • Hlubek F , SpadernaS, SchmalhoferO, JungA, KirchnerT, BrabletzT: Wnt/fzd signaling and colorectal cancer morphogenesis.Front. Biosci.12, 458–470 (2007).
  • Cannito S , NovoE, CompagnoneAet al.: Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells.Carcinogenesis29(12), 2267–2278 (2008).
  • Wu D , ZhauHE, HuangWCet al.: Camp-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis.Oncogene26(35), 5070–5077 (2007).
  • Liu YN , LiuY, LeeHJ, HsuYH, ChenJH: Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis.Mol. Cell. Biol.28(23), 7096–7108 (2008).
  • Wright MH , RoblesAI, HerschkowitzJIet al.: Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for BRCA1.Mol. Cancer7, 29 (2008).
  • Ye Y , XiaoY, WangW, YearsleyK, GaoJX, BarskySH: ERα suppresses slug expression directly by transcriptional repression.Biochem. J.416(2), 179–187 (2008).
  • Bracken CP , GregoryPA, KolesnikoffNet al.: A double-negative feedback loop between zeb1-sip1 and the microrna-200 family regulates epithelial–mesenchymal transition.Cancer Res.68(19), 7846–7854 (2008).
  • Cano A , NietoMA: Noncoding RNAs take centre stage in epithelial-to-mesenchymal transition.Trends Cell Biol.18(8), 357–359 (2008).
  • Katoh Y , KatohM: Hedgehog signaling, epithelial-to-mesenchymal transition and mirna (review).Int. J. Mol. Med.22(3), 271–275 (2008).
  • Paterson EL , KolesnikoffN, GregoryPA, BertAG, Khew-GoodallY, GoodallGJ: The microrna-200 family regulates epithelial to mesenchymal transition.ScientificWorldJournal8, 901–904 (2008).
  • Jiang YG , LuoY, HeDLet al.: Role of wnt/β-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1α.Int. J. Urol.14(11), 1034–1039 (2007).
  • Yook JI , LiXY, OtaIet al.: A wnt-axin2-gsk3β cascade regulates snail1 activity in breast cancer cells.Nat. Cell Biol.8(12), 1398–1406 (2006).
  • Peinado H , Del Carmen Iglesias-De La CruzM, OlmedaDet al.: A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression.EMBO J.24(19), 3446–3458 (2005).
  • Peinado H , Moreno-BuenoG, HardissonDet al.: Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.Cancer Res.68(12), 4541–4550 (2008).
  • Thiery JP , SleemanJP: Complex networks orchestrate epithelial-mesenchymal transitions.Nat. Rev. Mol. Cell Biol.7(2), 131–142 (2006).
  • Hazan RB , QiaoR, KerenR, BadanoI, SuyamaK: Cadherin switch in tumor progression.Ann. NY Acad. Sci.1014, 155–163 (2004).
  • Sarrio D , Rodriguez-PinillaSM, HardissonD, CanoA, Moreno-BuenoG, PalaciosJ: Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.Cancer Res.68(4), 989–997 (2008).
  • Aigner K , DescovichL, MikulaMet al.: The transcription factor zeb1 (δef1) represses plakophilin 3 during human cancer progression.FEBS Lett.581(8), 1617–1624 (2007).
  • Wang Z , WadeP, MandellKJet al.: Raf 1 represses expression of the tight junction protein occludin via activation of the zinc-finger transcription factor slug.Oncogene26(8), 1222–1230 (2007).
  • Kurrey NK , KA, BapatSA: Snail and slug are major determinants of ovarian cancer invasiveness at the transcription level.Gynecol. Oncol.97(1), 155–165 (2005).
  • Kominsky SL , ArganiP, KorzDet al.: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.Oncogene22(13), 2021–2033 (2003).
  • Usami Y , SatakeS, NakayamaFet al.: Snail-associated epithelial–mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.J. Pathol.215(3), 330–339 (2008).
  • Guarino M , RubinoB, BallabioG: The role of epithelial–mesenchymal transition in cancer pathology.Pathology39(3), 305–318 (2007).
  • Carpenter PM , Wang-RodriguezJ, ChanOT, WilczynskiSP: Laminin 5 expression in metaplastic breast carcinomas.Am. J. Surg. Pathol.32(3), 345–353 (2008).
  • Maschler S , WirlG, SpringHet al.: Tumor cell invasiveness correlates with changes in integrin expression and localization.Oncogene24(12), 2032–2041 (2005).
  • Takkunen M , AinolaM, VainionpaaNet al.: Epithelial–mesenchymal transition downregulates laminin α5 chain and upregulates laminin α4 chain in oral squamous carcinoma cells.Histochem. Cell Biol.130(3), 509–525 (2008).
  • Udayakumar TS , ChenML, BairELet al.: Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 β3 chain and induces cell migration.Cancer Res.63(9), 2292–2299 (2003).
  • Chaffer CL , BrennanJP, SlavinJL, BlickT, ThompsonEW, WilliamsED: Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.Cancer Res.66(23), 11271–11278 (2006).
  • Lee JM , DedharS, KalluriR, ThompsonEW: The epithelial–mesenchymal transition: new insights in signaling, development, and disease.J. Cell Biol.172(7), 973–981 (2006).
  • Brabletz T , HlubekF, SpadernaSet al.: Invasion and metastasis in colorectal cancer: epithelial–mesenchymal transition, mesenchymal-epithelial transition, stem cells and β-catenin.Cells Tissues Organs179(1–2), 56–65 (2005).
  • Thompson EW , NewgreenDF, TarinD: Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?Cancer Res.65(14), 5991–5995; discussion 5995 (2005).
  • Tarin D , ThompsonEW, NewgreenDF: The fallacy of epithelial mesenchymal transition in neoplasia.Cancer Res.65(14), 5996–6000; discussion 6000–5991 (2005).
  • Christiansen JJ , RajasekaranAK: Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.Cancer Res.66(17), 8319–8326 (2006).
  • Yauch RL , JanuarioT, EberhardDAet al.: Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients.Clin. Cancer Res.11(24 Pt 1), 8686–8698 (2005).
  • Van ‘T Veer LJ , DaiH, Van De VijverMJet al.: Gene expression profiling predicts clinical outcome of breast cancer.Nature415(6871), 530–536 (2002).
  • Ma XJ , WangZ, RyanPDet al.: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.Cancer Cell5(6), 607–616 (2004).
  • Strizzi L , BiancoC, NormannoNet al.: Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from mmtv-cripto-1 transgenic mice.J. Cell Physiol.201(2), 266–276 (2004).
  • Landesman-Bollag E , Romieu-MourezR, SongDH, SonensheinGE, CardiffRD, SeldinDC: Protein kinase ck2 in mammary gland tumorigenesis.Oncogene20(25), 3247–3257 (2001).
  • Damonte P , GreggJP, BorowskyAD, KeisterBA, CardiffRD: Emt tumorigenesis in the mouse mammary gland.Lab. Invest.87(12), 1218–1226 (2007).
  • Cardiff RD : Epithelial to mesenchymal transition tumors: Fallacious or snail’s pace?Clin. Cancer Res.11(24 Pt 1), 8534–8537 (2005).
  • Borowsky AD , NambaR, YoungLJet al.: Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior.Clin. Exp. Metastasis22(1), 47–59 (2005).
  • Radaelli E , ArnoldA, PapanikolaouAet al.: Mammary tumor phenotypes in wild-type aging female fvb/n mice with pituitary prolactinomas.Vet. Pathol.46(4), 736–745 (2009).
  • Pedram A , RazandiM, WallaceDC, LevinER: Functional estrogen receptors in the mitochondria of breast cancer cells.Mol. Biol. Cell17(5), 2125–2137 (2006).
  • Yang Z , BarnesCJ, KumarR: Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor a in breast cancer cells.Clin. Cancer Res.10(11), 3621–3628 (2004).
  • Mishra SK , TalukderAH, GururajAEet al.: Upstream determinants of estrogen receptor-α regulation of metastatic tumor antigen 3 pathway.J. Biol. Chem.279(31), 32709–32715 (2004).
  • Kumar R , WangRA, Bagheri-YarmandR: Emerging roles of mta family members in human cancers.Semin. Oncol.30(5 Suppl. 16), 30–37 (2003).
  • Blanco MJ , Moreno-BuenoG, SarrioDet al.: Correlation of snail expression with histological grade and lymph node status in breast carcinomas.Oncogene21(20), 3241–3246 (2002).
  • Jessen KA , LiuSY, TepperCGet al.: Molecular analysis of metastasis in a polyomavirus middle t mouse model: the role of osteopontin.Breast Cancer Res.6(3), R157–R169 (2004).
  • Cardiff RD , LederA, KuoA, PattengalePK, LederP: Multiple tumor types appear in a transgenic mouse with the ras oncogene.Am. J. Pathol.142(4), 1199–1207 (1993).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.